Article
No association between the TP53 codon 72 polymorphism and risk or prognosis of Hodgkin and non-Hodgkin lymphoma.
Leukemia research - 1 Aug 2011
Havranek Ondrej, Spacek Martin, Hubacek Petr, Mocikova Heidi, Benesova Katerina, Soucek Pavel, Trneny Marek, Kleibl Zdenek
Abstract excerpt
The role of the TP53 gene's R72P polymorphism in non-Hodgkin lymphoma (NHL) has been analyzed in several studies but it has not been studied in Hodgkin lymphoma (HL). We have evaluated the role of R72P in 340 NHL and 298 HL patients. There was no difference in the R72P frequency between analyzed lymphoma cases and 749 controls. We found no association of R72P with the risk of NHL and HL development...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
